Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) Piotroski F-Score: 6 (As of Aug. 31, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920566 Sichuan Zitonggong Pharmaceutical Co Ltd BJSE:920566
83 GF Score
Price ¥9.79
GF Value ¥10.55
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Sichuan Zitonggong Pharmaceutical Co Piotroski F-Score?

Sichuan Zitonggong Pharmaceutical Co BJSE:920566 83 Piotroski F-Score is 6 as of Aug. 31, 2026, which is at its 10-year median of 6.00. GuruFocus rates BJSE:920566 with a GF Score™ of 83/100 and a GF Value™ of ¥10.55 (Fairly Valued). The stock has 1 warning sign investors should review. Among 984 Drug Manufacturers companies, Sichuan Zitonggong Pharmaceutical Co ranks better than 78.15% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sichuan Zitonggong Pharmaceutical Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score or its related term are showing as below:

BJSE:920566' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Sichuan Zitonggong Pharmaceutical Co was 9. The lowest was 3. And the median was 6.

Sichuan Zitonggong Pharmaceutical Co  (BJSE:920566) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sichuan Zitonggong Pharmaceutical Co Piotroski F-Score Related Terms


Sichuan Zitonggong Pharmaceutical Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Zitonggong Pharmaceutical Co Piotroski F-Score Chart

Sichuan Zitonggong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 5.00 4.00 5.00

Sichuan Zitonggong Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 5.00 9.00 6.00

BJSE:920566 vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sichuan Zitonggong Pharmaceutical Co Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score falls into.


BJSE:920566
83GF Score
Sichuan Zitonggong Pharmaceutical Co Ltd BJSE:920566
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 20.686 + 27.576 + 24.183 + 12.672 = ¥85.1 Mil.
Cash Flow from Operations was 32.01 + 26.512 + 23.918 + 41.036 = ¥123.5 Mil.
Revenue was 105.761 + 121.467 + 106.095 + 104.345 = ¥437.7 Mil.
Gross Profit was 83.58 + 90.205 + 85.932 + 83.474 = ¥343.2 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(949.508 + 931.029 + 971.53 + 980.809 + 974.007) / 5 = ¥961.3766 Mil.
Total Assets at the begining of this year (Jun25) was ¥949.5 Mil.
Long-Term Debt & Capital Lease Obligation was ¥12.6 Mil.
Total Current Assets was ¥540.6 Mil.
Total Current Liabilities was ¥65.0 Mil.
Net Income was 17.728 + 28.433 + 16.642 + 18.773 = ¥81.6 Mil.

Revenue was 99.124 + 117.483 + 94.827 + 102.275 = ¥413.7 Mil.
Gross Profit was 78.052 + 90.052 + 70.405 + 80.314 = ¥318.8 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(879.288 + 895.389 + 921.068 + 936.355 + 949.508) / 5 = ¥916.3216 Mil.
Total Assets at the begining of last year (Jun24) was ¥879.3 Mil.
Long-Term Debt & Capital Lease Obligation was ¥12.8 Mil.
Total Current Assets was ¥550.7 Mil.
Total Current Liabilities was ¥68.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sichuan Zitonggong Pharmaceutical Co's current Net Income (TTM) was 85.1. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sichuan Zitonggong Pharmaceutical Co's current Cash Flow from Operations (TTM) was 123.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=85.117/949.508
=0.08964327

ROA (Last Year)=Net Income/Total Assets (Jun24)
=81.576/879.288
=0.09277506

Sichuan Zitonggong Pharmaceutical Co's return on assets of this year was 0.08964327. Sichuan Zitonggong Pharmaceutical Co's return on assets of last year was 0.09277506. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sichuan Zitonggong Pharmaceutical Co's current Net Income (TTM) was 85.1. Sichuan Zitonggong Pharmaceutical Co's current Cash Flow from Operations (TTM) was 123.5. ==> 123.5 > 85.1 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=12.626/961.3766
=0.01313325

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=12.788/916.3216
=0.0139558

Sichuan Zitonggong Pharmaceutical Co's gearing of this year was 0.01313325. Sichuan Zitonggong Pharmaceutical Co's gearing of last year was 0.0139558. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=540.552/65.019
=8.31375444

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=550.7/68.065
=8.09079556

Sichuan Zitonggong Pharmaceutical Co's current ratio of this year was 8.31375444. Sichuan Zitonggong Pharmaceutical Co's current ratio of last year was 8.09079556. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sichuan Zitonggong Pharmaceutical Co's number of shares in issue this year was 152.59. Sichuan Zitonggong Pharmaceutical Co's number of shares in issue last year was 143.83. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=343.191/437.668
=0.78413546

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=318.823/413.709
=0.77064555

Sichuan Zitonggong Pharmaceutical Co's gross margin of this year was 0.78413546. Sichuan Zitonggong Pharmaceutical Co's gross margin of last year was 0.77064555. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=437.668/949.508
=0.46094188

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=413.709/879.288
=0.47050454

Sichuan Zitonggong Pharmaceutical Co's asset turnover of this year was 0.46094188. Sichuan Zitonggong Pharmaceutical Co's asset turnover of last year was 0.47050454. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sichuan Zitonggong Pharmaceutical Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) has a Piotroski F-Score of 6 as of Aug. 31, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Sichuan Zitonggong Pharmaceutical Co and its competitors. This is near median its historical median of 6.00. Over the past decade, Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score has ranged from 3.00 to 9.00. According to the industry distribution chart, Sichuan Zitonggong Pharmaceutical Co ranks #215 out of 984 companies in the Drug Manufacturers industry, placing it in the top 21.8%.
Is Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score too high?
Sichuan Zitonggong Pharmaceutical Co's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Sichuan Zitonggong Pharmaceutical Co's value of 6 is 20% above this industry median. Based on the distribution chart, Sichuan Zitonggong Pharmaceutical Co ranks #215 out of 984 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sichuan Zitonggong Pharmaceutical Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Zitonggong Pharmaceutical Co's Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sichuan Zitonggong Pharmaceutical Co ranks #215 out of 984 companies for Piotroski F-Score. This places Sichuan Zitonggong Pharmaceutical Co in the top 22% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Sichuan Zitonggong Pharmaceutical Co's value of 6 is 20% above this benchmark. Historically, Sichuan Zitonggong Pharmaceutical Co's own Piotroski F-Score has ranged from 3.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Sichuan Zitonggong Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 984 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sichuan Zitonggong Pharmaceutical Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Sichuan Zitonggong Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sichuan Zitonggong Pharmaceutical Co's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Zitonggong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) is currently considered Fairly Valued. The stock's GF Value™ is ¥10.55, compared to a current price of ¥9.79 — trading 7.2% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Drug Manufacturers industry median of 5.00. Sichuan Zitonggong Pharmaceutical Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Sichuan Zitonggong Pharmaceutical Co (BJSE:920566), the current Piotroski F-Score is 6 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sichuan Zitonggong Pharmaceutical Co (BJSE:920566) Overvalued in 2026?

Based on GuruFocus' analysis, Sichuan Zitonggong Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥9.79 is trading 7.2% below its estimated GF Value™ of ¥10.55. GuruFocus considers Sichuan Zitonggong Pharmaceutical Co to be Fairly Valued.

Key valuation signals for BJSE:920566:

  • Piotroski F-Score: 6 (near median its 10-year median of 6.00)
  • GF Value™: ¥10.55 vs. price of ¥9.79 (7.2% below fair value)
  • GF Score™: 83/100 with 1 warning sign
  • Industry Position: 20% above the Drug Manufacturers median (#215 of 984)

No single metric tells the full story. See the BJSE:920566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sichuan Zitonggong Pharmaceutical Co Business Description

Address No. 456, Anji Street, Economic and Technological Development Zone, Sichuan Province, Neijiang, CHN, 641000
Sichuan Zitonggong Pharmaceutical Co Ltd is a high-tech enterprise focusing on the R&D, production, and marketing of tablets, hard capsules, liniments, powders, and ointments. It has developed a number of drug varieties, such as Citicoline Sodium Tablets and Rizatriptan Benzoate Capsules.
83GF Score

Get the complete analysis for BJSE:920566

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.79
Price
¥10.55
GF Value